Lemaitre Vascular INC 10-Q quarterly reports

LeMaitre Vascular, Inc. announced a 10% increase in net sales for Q2 2026, driven by strong performance in grafts, shunts, and patches, alongside improved gross margins.

LeMaitre Vascular, Inc. announced a 11% increase in net sales for Q1 2026, driven by strong performance in grafts, valvulotomes, and shunts, alongside improved gross margins.

LeMaitre Vascular, Inc. announced robust financial results for the third quarter and first nine months of 2025, driven by increased sales across all geographies and improved gross margins.

LeMaitre Vascular, Inc. announced robust financial results for Q2 2025, with net sales increasing 15% and net income rising 16.5% year-over-year, alongside significant corporate governance updates.

LeMaitre Vascular announces a 12% increase in net sales for the first quarter of 2025, driven by higher average selling prices and unit volumes.

LeMaitre Vascular's Q3 2024 results show significant growth in net sales and gross profit, driven by strong performance across all geographic regions and key product lines.

LeMaitre Vascular's Q2 2024 results show significant growth in net sales and gross profit, driven by higher average selling prices and strong procedure volumes.

LeMaitre Vascular's Q1 2024 results show a significant increase in net sales and gross profit, driven by higher average selling prices and increased procedure volumes.